Agents for Hepatocellular Carcinoma: Synthesis and Mode of Action
Ph.D
Saved in:
Main Author: | CHEN XIAO |
---|---|
Other Authors: | PHARMACY |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/77727 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma
by: Lee, S.-C., et al.
Published: (2012) -
OVEREXPRESSION OF TYRO3 AND ITS IMPLICATION ON HEPATOCELLULAR CARCINOMA (HCC) PROGRESSION
by: DUAN YAN
Published: (2011) -
ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft
by: Jasinghe, V.J., et al.
Published: (2011) -
HEPN1, a novel gene that is frequently down-regulated in hepatocellular carcinoma, suppresses cell growth and induces apoptosis in HepG2 cells
by: Moh, M.C., et al.
Published: (2016) -
HEPN1, a novel gene that is frequently down-regulated in hepatocellular carcinoma, suppresses cell growth and induces apoptosis in HepG2 cells
by: Moh, M.C., et al.
Published: (2011)